Back to results

TerminatedPhase 3

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction

NCT01536015

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

011

Birmingham, Alabama, United States

+25 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-01
Enrollment: 25 participants
Sponsor: UCB Pharma
Purpose: treatment

Locations (26)

011Birmingham, Alabama, United States
001Gilbert, Arizona, United States
022Fountain Valley, California, United States
017Irvine, California, United States
028Pasadena, California, United States
015Sunnyvale, California, United States
008Gainesville, Florida, United States
009Miami, Florida, United States
010Ormond Beach, Florida, United States
006Sunrise, Florida, United States
032Annapolis, Maryland, United States
027Lincoln, Nebraska, United States
016Commack, New York, United States
026Mineola, New York, United States
034Charlotte, North Carolina, United States
002Raleigh, North Carolina, United States
007Salisbury, North Carolina, United States
021Toledo, Ohio, United States
023Tulsa, Oklahoma, United States
031Cordova, Tennessee, United States
018Memphis, Tennessee, United States
014Houston, Texas, United States
030Richmond, Virginia, United States
003Virginia Beach, Virginia, United States
012Kirkland, Washington, United States
013Milwaukee, Wisconsin, United States

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction — TrialFind